Pathology Bellevue Nyu Medcent New York City, NY - 10016

Pathology Bellevue Nyu Medcent is categorized under Pathological Laboratories in New York City, NY and active since 1998.

Pathology Bellevue Nyu Medcent was established in 1998, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 621511 by the NAICS.

If you are seeking more information, feel free to contact Judith Aberg at the company’s single location by writing to 462 1st Avenue Front, New York City, New York NY 10016 or by phoning (212) 562-3411. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pathology Bellevue Nyu Medcent
Contact Person: Judith Aberg
Address: 462 1st Avenue Front, New York City, New York 10016
Phone Number: (212) 562-3411
Annual Revenue (USD): $100.000 to $499.999
Founded: 1998
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Pathological Laboratories
SIC Code: 8071
NAICS Code: 621511
Share This Business:

Pathology Bellevue Nyu Medcent was started in 1998 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Judith Aberg for inquiries that concern Pathology Bellevue Nyu Medcent by calling the company number (212) 562-3411, as your correspondence is most welcome. Additionally, the physical location of the single location of Pathology Bellevue Nyu Medcent can be found at the coordinates 40.739659,-73.976311 as well as the street address 462 1st Avenue Front in New York City, New York 10016.

For its online presence, you may visit Pathology Bellevue Nyu Medcent’s website at and engage with its social media outlets through on Twitter and on Facebook.